The President and other Republicans are currently making regulations requiring drug companies to charge US customers the same low rates they charge international customers. The price difference is entirely in the price charged, this isn't a case of single payers offsetting the cost.
The US public has been subsidizing pharmaceutical research for the entire world with these inflated prices and hopefully that changes soon.